Jung Han Yoon1, Ji Eun Lee, Seok Woo Yong, So Young Moon, Phil Hyu Lee. 1. *Department of Neurology, Ajou University School of Medicine, Suwon †Department of Neurology ‡Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, Korea.
Abstract
BACKGROUND: Recent studies have demonstrated that structural and pathologic changes are more severe in patients with dementia with Lewy bodies (DLB) than in those with Parkinson disease with dementia (PDD). We investigated neuropsychological characteristics of patients with mild cognitive impairment (MCI) stage of DLB (DLB-MCI) and PD (PD-MCI) based on the hypothesis that the pathologic differences between DLB and PDD can influence cognitive profiles in the MCI stage of these diseases. METHODS: Baseline demographic characteristics and neuropsychological data obtained from patients with DLB-MCI (n=20) and PD-MCI (n=46) were compared. RESULTS: The patients with DLB-MCI showed poorer cognitive performance in the Stroop, Go-No-Go, and semantic fluency tests compared with those with PD-MCI. In addition, patients with DLB-MCI had lower scores on visual and verbal memory performance and in the visuospatial domain compared with PD-MCI patients. CONCLUSIONS: Our results demonstrate that patients with DLB-MCI have more severe cognitive impairment in frontal executive, memory, and visuospatial functions than those with PD-MCI. These data suggest that differences in pathologic substrates between PDD and DLB may begin in the MCI stage of the 2 diseases and may lead to differences in cognitive profiles.
BACKGROUND: Recent studies have demonstrated that structural and pathologic changes are more severe in patients with dementia with Lewy bodies (DLB) than in those with Parkinson disease with dementia (PDD). We investigated neuropsychological characteristics of patients with mild cognitive impairment (MCI) stage of DLB (DLB-MCI) and PD (PD-MCI) based on the hypothesis that the pathologic differences between DLB and PDD can influence cognitive profiles in the MCI stage of these diseases. METHODS: Baseline demographic characteristics and neuropsychological data obtained from patients with DLB-MCI (n=20) and PD-MCI (n=46) were compared. RESULTS: The patients with DLB-MCI showed poorer cognitive performance in the Stroop, Go-No-Go, and semantic fluency tests compared with those with PD-MCI. In addition, patients with DLB-MCI had lower scores on visual and verbal memory performance and in the visuospatial domain compared with PD-MCIpatients. CONCLUSIONS: Our results demonstrate that patients with DLB-MCI have more severe cognitive impairment in frontal executive, memory, and visuospatial functions than those with PD-MCI. These data suggest that differences in pathologic substrates between PDD and DLB may begin in the MCI stage of the 2 diseases and may lead to differences in cognitive profiles.
Authors: Angelina R Sutin; Yannick Stephan; Rodica Ioana Damian; Martina Luchetti; Jason E Strickhouser; Antonio Terracciano Journal: Psychol Aging Date: 2019-05
Authors: Steven Bunt; Rónán O'Caoimh; Wim P Krijnen; D William Molloy; Geert Pieter Goodijk; Cees P van der Schans; Hans J S M Hobbelen Journal: BMC Geriatr Date: 2015-10-02 Impact factor: 3.921
Authors: Bradley F Boeve; Dennis W Dickson; John E Duda; Tanis J Ferman; Douglas R Galasko; James E Galvin; Jennifer G Goldman; John H Growdon; Howard I Hurtig; Daniel I Kaufer; Kejal Kantarci; James B Leverenz; Carol F Lippa; Oscar L Lopez; Ian G McKeith; Andrew B Singleton; Angela Taylor; Debby Tsuang; Daniel Weintraub; Cyrus P Zabetian Journal: Mov Disord Date: 2016-08-05 Impact factor: 10.338
Authors: Ian G McKeith; Tanis J Ferman; Alan J Thomas; Frédéric Blanc; Bradley F Boeve; Hiroshige Fujishiro; Kejal Kantarci; Cristina Muscio; John T O'Brien; Ronald B Postuma; Dag Aarsland; Clive Ballard; Laura Bonanni; Paul Donaghy; Murat Emre; James E Galvin; Douglas Galasko; Jennifer G Goldman; Stephen N Gomperts; Lawrence S Honig; Manabu Ikeda; James B Leverenz; Simon J G Lewis; Karen S Marder; Mario Masellis; David P Salmon; John Paul Taylor; Debby W Tsuang; Zuzana Walker; Pietro Tiraboschi Journal: Neurology Date: 2020-04-02 Impact factor: 9.910